CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
https://doi.org/10.38109/2225-1685-2020-4-6-10
Abstract
Aim. The aim of the study was to assess the incidence of CI-AKI in patients with stable CAD in 2012 and 2017 respectively.
Materials and methods. 1023 patients with stable CAD and indications to the interventions with intraarterial contrast media administration were included in the study. 561 patients were enrolled in the study in 2012 and 462 in 2017 respectively& We conducted a prospective open cohort study (ClinicalTrials.gov NCT04014153). Preventive measures included the administration of 0,9% saline with the speed 1 ml/kg/h intravenously and 0,5 kg/ml/h for the patients with heart failure before and after the procedure. The patients enrolled in 2017 were older, had higher BMI and more risk factors of CI-AKI development. The primary endpoint was the development of CI-AKI.
Results. The rate of CI-AKI decreased by more than 3 times in 2017 in comparison with 2012 (6% vs. 18,5% respectively), in spite of the increase of the age of patients, increased use of metformin and higher number of risk factors. The difference was statistically significant (р<0,0001).
Conclusion. The prevalence of CI-AKI decreased 3 times in 2017 in comparison with 2012 (6% vs. 18,5% respectively), in spite of the increase of the age of patients and the number of their comorbidities. These results were obtained due to higher level of education of the doctors about the syndrome, preventive measures and methods of treatment.
About the Authors
O. Iu. MironovaRussian Federation
Cand. of Sci. (Med.), docent of the Department of Faculty Therapy No. 1 of the Institute of Clinical Medicine
named after N.V. Sklifosovsky
119435, Moscow, st. Bol. Pirogovskaya, 6, bldg. 1
V. V. Fomin
Russian Federation
Corresponding Member of the RAS, Professor, Dr. of Sci. (Med.), Vice-Rector for Clinical Work and Additional Professional Education, Head of the Department of Faculty Therapy No. 1 of the Institute of Clinical Medicine. N.V. Sklifosovsky
119435, Moscow, st. Bol. Pirogovskaya, 6, bldg. 1
References
1. Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovasc Interv Ther [Internet]. 2020;35(3):209–17. Available from: https://doi.org/10.1007/s12928-020-00660-8
2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–64.
3. Alshaikh HN, Katz NM, Gani F, Nagarajan N, Canner JK, Kacker S, et al. Financial Impact of Acute Kidney Injury After Cardiac Operations in the United States. Ann Thorac Surg [Internet]. 2018;105(2):469–75. Available from: https://doi.org/10.1016/j.athoracsur.2017.10.053
4. Kooiman J, Seth M, Nallamothu BK, Heung M, Humes D, Gurm HS. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv. 2015;8(6):1–8.
5. James MT, Ghali WA, Tonelli M, Faris P, Knudtson ML, Pannu N, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int [Internet]. 2010;78(8):803–9. Available from: http://dx.doi.org/10.1038/ki.2010.258
6. van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin M-F, Bertolotto M, et al. Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors. Eur Radiol. 2018;28(7):2845–55.
7. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrast-induced acute kidney injury: Incidence, evolution, risk factors, and prognosis. Circulation. 2012;125(25):3099–107.
8. Gurm HS, Seth M, Dixon S, Kraft P, Jensen A. Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2). JACC Cardiovasc Interv [Internet]. 2018;11(5):509–11. Available from: https://doi.org/10.1016/j.jcin.2017.10.018
9. Amin AP, Salisbury AC, McCullough PA, Gosch K, Spertus JA, Venkitachalam L, et al. Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med. 2012;172(3):246–53.
10. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl [Internet]. 2012;2(1):3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2157171615310406
11. Williams B, Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. 2018 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2018;25(6):1105–87.
12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129-2200m.
13. Khanna D, Fitzegarld J, Khanna P, Bae S, Singh M. 2012 American College of Rheumatology Guidelines for Management of Gout Part I: Systematic Non-pharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia. Arthritis Care Res [Internet]. 2012;64(10):1431–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3683400%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC368044
14. Alimentary anemias. Report of the WHO scientific group. 1970 (in Russ.)
15. Kellum JA, Zarbock A, Nadim MK. What endpoints should be used for clinical studies in acute kidney injury? Intensive Care Med [Internet]. 2017;43(6):901–3. Available from: https://doi.org/10.1007/s00134-017-4732-1
Review
For citations:
Mironova O.I., Fomin V.V. CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE. Eurasian heart journal. 2020;(4):6-10. (In Russ.) https://doi.org/10.38109/2225-1685-2020-4-6-10